Miconazole%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520vaginal%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520pessary

# Miconazole Vaginal Pessary ## Overview Miconazole vaginal pessary is a topical antifungal agent used for the treatment of vulvovaginal candidiasis (yeast infections). ## Primary Indications * Vulvovaginal candidiasis (yeast infections) ## Adult Dosing * **100 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 7 days. * **200 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 3 days. * **100 mg vaginal suppository (often referred to as a pessary in common use):** Insert one suppository vaginally at bedtime for 7 days. * **200 mg vaginal suppository (often referred to as a pessary in common use):** Insert one suppository vaginally at bedtime for 3 days. * **Higher strength suppositories (e.g., 1200 mg single dose) may also be available.** Insert one suppository vaginally as a single dose. The specific strength and duration depend on the product formulation and clinical judgment. ## Pediatric Dosing Dosing for pediatric patients is not well-established for vaginal pessaries. Use in children should be based on a healthcare provider's recommendation and may involve different formulations or dosing strategies. ## Dose Adjustments No dose adjustments are typically required based on renal or hepatic impairment as systemic absorption is minimal. ## Contraindications * Hypersensitivity to miconazole or any component of the formulation. ## Adverse Effects * Vaginal burning or itching * Pelvic cramps * Lower abdominal pain * Headache * Rash ## Key Drug Interactions * **Warfarin:** Miconazole may inhibit CYP3A4 and CYP2C9 enzymes, leading to increased warfarin levels and a higher risk of bleeding. Close monitoring of INR is recommended if used concurrently. * **CYP3A4 substrates:** Concurrent use with other drugs metabolized by CYP3A4 may lead to increased plasma concentrations of those drugs. ## Monitoring * Monitor for signs and symptoms of vaginal candidiasis to assess treatment efficacy. * Monitor for adverse effects. * If concomitant warfarin therapy, monitor INR closely. ## Clinical Pearls * Ensure the applicator is used correctly for proper insertion. * Treatment should be completed as directed, even if symptoms improve earlier. * Avoid sexual intercourse during treatment to prevent potential irritation or transmission. * If symptoms do not improve after completing the course, or if they worsen, re-evaluate the diagnosis and consider alternative treatments. * Pregnancy: While systemic absorption is low, consult prescribing information and healthcare provider for use during pregnancy, particularly in the first trimester. *** **Disclaimer:** This information is intended for healthcare professionals and does not substitute for professional medical advice. Always consult the official prescribing information and your healthcare provider for diagnosis, treatment, and management of medical conditions. Dosing and recommendations may vary based on individual patient factors, local protocols, and product availability.